Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Dose-Reduced Chemotherapy in Elderly ALL
NCT00199095Phase 4Completed
- Sponsor
- Goethe University Frankfurt
- Start
- Feb 1997
- Primary completion
- Jun 2003
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doxorubicin, cyclophosphamide, cytarabine, dexamethasone, idarubicin in acute lymphoblastic leukemia (ALL), sponsored by Goethe University Frankfurt. Started Feb 1997; status: completed.
02
Drugs
doxorubicincyclophosphamidecytarabinedexamethasoneidarubicin
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00199095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00199095.